Amanda Cannon
Adult Health · Kenly, NCNPI 1245632157
Payments from drug & device makers
Across 49 payments — averaging $27.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$518
- Amgen$263
- AstraZeneca$124
- AbbVie$77
- Boehringer Ingelheim$50
- Otsuka America Pharmaceutical, Inc.$37
- plus $282 from 15 others
What the payments were for
- Food & beverage$1,352100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 15 | $518 |
| Amgen | 5 | $263 |
| AstraZeneca | 5 | $124 |
| AbbVie | 4 | $77 |
| Boehringer Ingelheim | 2 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| GSK | 2 | $32 |
| Johnson & Johnson | 1 | $24 |
| Sunovion Pharmaceuticals Inc. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Eisai Inc. | 1 | $15 |
| Scpharmaceuticals Inc. | 1 | $15 |
| Novartis | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Pfizer | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prolia$215
How this compares
$1,352 in reported general payments places this provider in the 70th percentile of 614 adult health providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 61 | $68,763 |
| MounjaroTirzepatide | 36 | $44,129 |
| EliquisApixaban | 60 | $38,947 |
| LinzessLinaclotide | 22 | $26,884 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $19,773 |
| Tresiba Flextouch U-100Insulin Degludec | 13 | $10,865 |
| XareltoRivaroxaban | 13 | $9,020 |
| Advair HfaFluticasone Propion/Salmeterol | 21 | $8,742 |
| Repatha SureclickEvolocumab | 11 | $8,516 |
| MyrbetriqMirabegron | 15 | $6,393 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $5,907 |
| GemtesaVibegron | 12 | $5,858 |
| TrintellixVortioxetine Hydrobromide | 11 | $5,422 |
| Omeprazole | 168 | $1,950 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 61 | $1,843 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $518 | $68,76361 claims |
| Lilly USA, LLCMounjaro | $20 | $44,12936 claims |
| PfizerEliquis | $14 | $38,94760 claims |
| AbbVieLinzess, Synthroid | $77 | $28,23941 claims |
| GSKTrelegy Ellipta | $32 | $19,77315 claims |
| Johnson & JohnsonXarelto | $24 | $9,02013 claims |
| Astellas Pharma US IncMyrbetriq | $20 | $6,39315 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $21 | $5,85812 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $15 | $5,42211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 614 adult health providers in North Carolina.
Other adult health in Kenly
- Robert DodgeRaleigh$311K
- Kimberly CampDurham$147K
- Henry VanpalaRaleigh$110K
- Jolene SpencerWashington$83K
- Felicia RichardsonGreenville$64K
- Anna BooneReidsville$51K
- Chaely MedleyChapel Hill$47K
- Ann ShumDurham$35K
- Amy HopkinsGreenville$31K
- Stephanie YatesDurham$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.